Mycoplasma pneumonia medical therapy
|
Mycoplasma pneumonia Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mycoplasma pneumonia medical therapy On the Web |
|
American Roentgen Ray Society Images of Mycoplasma pneumonia medical therapy |
|
Risk calculators and risk factors for Mycoplasma pneumonia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Antimicrobial therapy is the mainstay of therapy for atypical pneumonia caused by Mycoplasma. Pharmacologic therapies for Mycoplasma pneumonia include either a macrolide (e.g. azithromycin) for 2-5 days, doxycycline for 14 days, or a fluoroquinolone for 14 days. Supportive therapy includes rest, adequate fluid intake, and administration of either non-steroidal anti-inflammatory drugs (NSAIDS) or acetaminophen if needed. Aspirin should be avoided among children.
Medical Therapy
Supportive Care
- Supportive therapy includes rest, adequate fluid intake, and administration of either nonsteroidal anti-inflammatory drugs (NSAIDS) or acetaminophen if needed.
- Aspirin should be avoided among children.
Antimicrobial Regimen
All patients diagnosed with Mycoplasma pneumonia are treated with antimicrobial therapy.
-
- Preferred regimen (1): Azithromycin 500 mg PO qd on day 1 and 250 mg PO qd on days 2 to 5
- Preferred regimen (2): Clarithromycin 500 mg PO qd for 14 days
- Preferred regimen (3): Moxifloxacin 400 mg PO qd for 14 days
- Preferred regimen (4): Levofloxacin 750 mg PO qd for 14 days
- Alternative regimen : Doxycycline 100 mg PO bid for 14 days
References
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.